NEW YORK (GenomeWeb News) – On the heels of Roche's extension of its hostile takeover bid and in anticipation of its annual shareholders' meeting next month, Illumina today sent a second letter to its shareholders to vote reject Roche's efforts to acquire the San Diego-based firm.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.